[HTML][HTML] Characterizing the incidence of adverse events of special interest for COVID-19 vaccines across eight countries: a multinational network cohort study

X Li, A Ostropolets, R Makadia, A Shaoibi, G Rao… - Medrxiv, 2021 - ncbi.nlm.nih.gov
Background As large-scale immunization programs against COVID-19 proceed around the
world, safety signals will emerge that need rapid evaluation. We report population-based,
age-and sex-specific background incidence rates of potential adverse events of special
interest (AESI) in eight countries using thirteen databases. Methods This multi-national
network cohort study included eight electronic medical record and five administrative claims
databases from Australia, France, Germany, Japan, Netherlands, Spain, the United …

Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study

X Li, A Ostropolets, R Makadia, A Shoaibi, G Rao… - bmj, 2021 - bmj.com
Objective To quantify the background incidence rates of 15 prespecified adverse events of
special interest (AESIs) associated with covid-19 vaccines. Design Multinational network
cohort study. Setting Electronic health records and health claims data from eight countries:
Australia, France, Germany, Japan, the Netherlands, Spain, the United Kingdom, and the
United States, mapped to a common data model. Participants 126 661 070 people observed
for at least 365 days before 1 January 2017, 2018, or 2019 from 13 databases. Main …